DRUG TESTING GOES OFFSHORE.

Discusses the ethical debate over conducting clinical trials in developing countries. Reasons why 40% of all trials are conducted in poor countries such as Russia and India, including the economic benefits; How trials in poor countries allow drugs to reach the market faster; Issues surrounding the U.S. Food & Drug Administration's oversight of foreign clinical trials; Question of whether foreign drug trials exploit the vulnerability of poor patients; Analysis of the issue.